{"id":1134,"slug":"再生医学里-哪些治疗已经是成熟的常规医疗-哪些还只是研究阶段","question":"再生医学里，哪些治疗已经是成熟的常规医疗，哪些还只是研究阶段？","intent":"comparison","language":"zh","url":"https://worldwiki.io/q/再生医学里-哪些治疗已经是成熟的常规医疗-哪些还只是研究阶段","entity":{"slug":"regenerative-medicine","name":"Regenerative Medicine","url":"https://worldwiki.io/entity/regenerative-medicine"},"answer":{"short_answer":"按公开资料，造血干细胞移植属于已确立的临床实践，而再生医学的许多其他用途至今仍处于研究阶段。[3][7] 这条分界线是判断宣传真伪最实用的标准：一项疗法若被描述为可治疗多种不相关的疾病，通常需要格外警惕。ISSCR 的研究与临床转化指南及其患者资料，提供了从研究走向临床应认定的步骤。[8][9]","detailed_answer":"

阅读任何再生医学宣传时，可按以下顺序核对：

  1. 这属于已确立的实践（如造血干细胞移植），还是研究阶段的探索？[3][7]
  2. 若属研究阶段，是否有正式的临床研究编号、伦理审查与知情同意？
  3. 产品是否有所在国的批准文号？认定或备案不等于批准。[2][5][6]
  4. 监管机构是否可查？韩国为保健福祉部与食品医药品安全处，美国为 FDA。[1][6]
","format":"paragraph","confidence":75,"verified_at":null,"updated_at":"2026-09-20 17:11:10"},"sources":[{"id":3,"title":"Ministry of Food and Drug Safety — English site","url":"https://www.mfds.go.kr/eng/","publisher":"MFDS, Republic of Korea","type":"government","accessed_at":"2026-09-18 18:00:01"},{"id":2,"title":"FDA Warns About Stem Cell Therapies","url":"https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies","publisher":"U.S. Food and Drug Administration","type":"government","accessed_at":"2026-09-15 01:35:59"},{"id":249,"title":"Regenerative medicine: Historical roots and potential strategies in modern medicine","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6014277/","publisher":"Journal of Microscopy and Ultrastructure (via PubMed Central, NIH)","type":"journal","accessed_at":"2026-09-19 18:00:20"},{"id":250,"title":"Regenerative Medicine Advanced Therapy Designation","url":"https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation","publisher":"U.S. Food and Drug Administration","type":"government","accessed_at":"2026-09-19 18:00:20"},{"id":96,"title":"Important Patient and Consumer Information About Regenerative Medicine Therapies","url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies","publisher":"U.S. Food and Drug Administration","type":"government","accessed_at":"2026-09-18 18:00:38"},{"id":1,"title":"Stem Cell Basics","url":"https://stemcells.nih.gov/info/basics","publisher":"National Institutes of Health (NIH)","type":"government","accessed_at":"2026-09-15 01:35:59"},{"id":14,"title":"ISSCR Guidelines for Stem Cell Research and Clinical Translation","url":"https://www.isscr.org/guidelines","publisher":"International Society for Stem Cell Research","type":"organization","accessed_at":"2026-09-19 18:01:07"},{"id":15,"title":"About Stem Cells — patient resource","url":"https://www.aboutstemcells.org/","publisher":"International Society for Stem Cell Research","type":"organization","accessed_at":"2026-09-19 18:01:05"}],"published_at":"2026-09-20 08:11:10"}